Respiratory Syncytial Virus: Current Progress in Vaccine Development

Author： Rudraraju Rajeev Jones Bart G. Sealy Robert Surman Sherri L. Hurwitz Julia L.

Publisher： MDPI

E-ISSN： 1999-4915|5|2|577-594

ISSN： 1999-4915

Source： Viruses, Vol.5, Iss.2, 2013-02, pp. : 577-594

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia—Implications for Vaccine Design

By Rey-Jurado Emma Kalergis Alexis M.

International Journal of Molecular Sciences, Vol. 18, Iss. 3, 2017-03 ,pp. : 556-556

MDPI

Access to resources Recommend Favorite

Th17 Lymphocytes in Respiratory Syncytial Virus Infection

By Bystrom Jonas Al-Adhoubi Nasra Al-Bogami Mohammed Jawad Ali S. Mageed Rizgar A.

Viruses, Vol. 5, Iss. 3, 2013-03 ,pp. : 777-791

MDPI

Access to resources Recommend Favorite

Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus

By Jorquera Patricia A. Tripp Ralph A.

Vaccines, Vol. 4, Iss. 4, 2016-12 ,pp. : 45-45

MDPI

Access to resources Recommend Favorite

Transmission of Human Respiratory Syncytial Virus in the Immunocompromised Ferret Model

By de Waal Leon Smits Saskia L. Veldhuis Kroeze Edwin J. B. van Amerongen Geert Pohl Marie O. Osterhaus Albert D. M. E. Stittelaar Koert J.

Viruses, Vol. 10, Iss. 1, 2018-01 ,pp. : 18-18

MDPI

Access to resources Recommend Favorite

Respiratory Syncytial Virus Persistence in Macrophages Alters the Profile of Cellular Gene Expression

By Rivera-Toledo Evelyn Gómez Beatríz

Viruses, Vol. 4, Iss. 12, 2012-11 ,pp. : 3270-3280

MDPI

Access to resources Recommend Favorite